XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s): XRTX

Healthcare

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.

TSXV:XRTX - Post by User

XORTX Therapeutics Inc > Analyst : XORTX Price target $27 USD

<< Previous

Bullboard Posts

Next >>

Comment by SpaceLabson Sep 30, 2021 12:26pm

152 Views

Post# 33946225

RE:Analyst : XORTX Price target $27 USD

Now I can see HOPE from my friend Anklebiter42 and I will stick to your advice bro.
You are upto date with stock information and i shall be listening to you. I went to Barrons site and looks pretty good when INDICATOR is STRONG BUY !

Thanks for this AB42, now i will make some money on my $2000 in XRX and I will buy more on its way UP !
Thx again dude, lets get listed on NASDAQ.
Any idea about #of shrs to be IPO'd?